Company Deep Dive

Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.

View Deep Dive

TMCI

SELL

Treace Medical Concepts, Inc. · Healthcare · United States · $289M · Avg Vol: $4M/d

33
StockRank
Get insider-trade alerts
Q
37
V
32
M
56
P/E (TTM)
—
ROE
-66.9%
D/E
0.9x
Dividend %
—
Dir. Trades · 180d
+$1.2M →
Buybacks · 180d
None →

COMPANY DESCRIPTION

Treace Medical Concepts, Inc. is a medical device company focused on advancing the standard of care for bunion surgery through its proprietary Lapiplasty 3D Bunion Correction system. The company's competitive moat is established by its unique instrumentation, extensive clinical data supporting superior patient outcomes, and a highly specialized direct sales force. It operates as a dominant niche leader in the foot and ankle orthopedic market.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGRTTM2026E2027EFwd CAGR
Revenue141.8M187.1M209.4M212.7M14.5%207.3M206.3M221.8M2.1%
EPS-0.77-0.81-0.90-0.93—-1.04-0.91-0.90—
Shares55.6M61.7M62.4M63.9M+14.8%64.9M———
Debt68.6M70.3M69.7M71.9M1.6%71.6M———
Equity60.5M137.9M112.9M87.3M13.0%————
Op CF-30.6M-34.6M-37.2M-16.0M—-12.9M———
Inv CF-76.5M-81.3M35.4M13.3M—————
Fin CF20.8M109.4M0.2M2.1M—————
Loading 1Y...
PRICE (1Y)+30.3%
3.403.724.034.344.66Jun 3Jun 25Jul 16
SMA 50SMA 200
Close
$4.43
RSI (14)
49.6
52W High
$7.78
From 52W High
0.6%

SCORE BREAKDOWN

Quality
37
ROIC
-33.6%20.3
ROE
-66.9%13.4
GP/Assets
86.7%96.9
Op. Margin
-36.4%22.8
FCF/Assets
-3.0%37.5
Piotroski
25.7
Int. Cover
-10.1x22.4
D/E Ratio
0.93x16.1
Current Ratio
3.58x60.3
Value
32
P/E (TTM)
—N/A
EV/EBITDA
-6.8x25.0
P/FCF
—N/A
P/B
3.9x34.9
P/S
1.5x75.7
Div Yield
—N/A
Momentum
56
52W High %
57%33.4
RS 6M
55%94.3
SMA 50/200
1.13x84.2
EPS Rev 4W
0.0%64.6
EPS Rev 12W
—N/A
EPS Improve
+13%28.3
Q Growth
—N/A

FUNDAMENTALS

Market Cap
$289M
P/E (Forward)
-5.2x
Gross Margin
79.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of TMCI are excluded.

TickerCompanyMkt CapStockRankSignal
TMCITreace Medical Concepts, Inc.(you)$289M33SELL
APYXApyx Medical Corporation$188M35SELL
LABStandard BioTools Inc.$287M21SELL
RXSTRxSight, Inc.$222M24SELL
SGHTSight Sciences, Inc.$310M19STRONG SELL
NPCENeuroPace, Inc.$562M36HOLD
MXCTMaxCyte, Inc.$133M31SELL
CTKBCytek Biosciences, Inc.$579M36HOLD
CATXPerspective Therapeutics, Inc.$347M18STRONG SELL
TLSITriSalus Life Sciences, Inc.$291M14STRONG SELL

Peer medians: ROE -21.2% · P/E 27.3x · Gross margin 48.9%

Treace Medical Concepts, Inc. (TMCI) — Stock Score Summary

Treace Medical Concepts, Inc. (TMCI) has a MoatMap StockRank of 33/100 based on Quality (37/100), Value (32/100), and Momentum (56/100) factor scores. The current signal is SELL.

Treace Medical Concepts, Inc. is a medical device company focused on advancing the standard of care for bunion surgery through its proprietary Lapiplasty 3D Bunion Correction system. The company's competitive moat is established by its unique instrumentation, extensive clinical data supporting superior patient outcomes, and a highly specialized direct sales force. It operates as a dominant niche leader in the foot and ankle orthopedic market.

Key Financial Metrics

Price$4.43
Market Cap$289M
P/E (Forward)-5.18
Price/Book3.91
Return on Equity-66.9%
Return on Invested Capital-33.6%
Debt/Equity0.93x
Gross Margin79.7%
Operating Margin-36.4%
Revenue Growth-10.2%
Free Cash Flow$-6M

Treace Medical Concepts, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Treace Medical Concepts, Inc.’s (TMCI) StockRank?
MoatMap’s StockRank for Treace Medical Concepts, Inc. (TMCI) is 33/100, with a Sell signal. It is a composite of Quality (37), Value (32), and Momentum (56) factor ranks across MoatMap’s 20,000+ stock universe.
Does Treace Medical Concepts, Inc. have an economic moat?
Treace Medical Concepts, Inc. (TMCI) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Treace Medical Concepts, Inc. a buy, hold, or sell?
MoatMap’s current signal for Treace Medical Concepts, Inc. (TMCI) is Sell, based on a StockRank of 33/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Treace Medical Concepts, Inc. in?
Treace Medical Concepts, Inc. (TMCI) operates in the Healthcare sector, specifically the Medical Devices industry (United States).
Browse all ranked stocksTMCI deep dive reportAI ChampionsHow we score stocksSense-check another stock